Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Memantine"" wg kryterium: Temat


Tytuł :
Effects of memantine and its metabolite Mrz 2/373 on soman-induced inhibition of acetylcholinesterase in vitro.
Autorzy :
Stojiljković MP; Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, the Republic of Srpska, Bosnia and Herzegovina; National Poison Control Centre, Military Medical Academy, University of Defence, Belgrade, Serbia. Electronic address: .
Škrbić R; Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, the Republic of Srpska, Bosnia and Herzegovina.
Jokanović M; Experta Consulting, Belgrade, Serbia.
Kilibarda V; National Poison Control Centre, Military Medical Academy, University of Defence, Belgrade, Serbia.
Bokonjić DR; National Poison Control Centre, Military Medical Academy, University of Defence, Belgrade, Serbia.
Maksimović M; National Poison Control Centre, Military Medical Academy, University of Defence, Belgrade, Serbia.
Pokaż więcej
Źródło :
Chemico-biological interactions [Chem Biol Interact] 2021 Jun 01; Vol. 342, pp. 109463. Date of Electronic Publication: 2021 Apr 05.
Typ publikacji :
Journal Article
MeSH Terms :
Cholinesterase Inhibitors/*pharmacology
Memantine/*pharmacology
Soman/*pharmacology
Animals ; Cattle ; Cholinesterase Inhibitors/chemistry ; Dopamine Agents/pharmacology ; Drug Tapering ; Memantine/chemistry ; Memantine/metabolism ; Molecular Structure ; Time Factors
Czasopismo naukowe
Tytuł :
Memantine ameliorates cognitive impairment induced by exposure to chronic hypoxia environment at high altitude by inhibiting excitotoxicity.
Autorzy :
Ji W; Research Center for High Altitude Medicine, Qinghai University, Xining, China; Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province (Qinghai-Utah Loint Research Key Lab for High Altitude Medicine), Xining, China; Qinghai Provincial People's Hospital, Xining, China.
Zhang Y; Qinghai Provincial People's Hospital, Xining, China.
Luo J; Qinghai Provincial People's Hospital, Xining, China.
Wan Y; Research Center for High Altitude Medicine, Qinghai University, Xining, China; Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province (Qinghai-Utah Loint Research Key Lab for High Altitude Medicine), Xining, China; Qinghai Provincial People's Hospital, Xining, China.
Liu J; Qinghai Provincial People's Hospital, Xining, China.
Ge RL; Research Center for High Altitude Medicine, Qinghai University, Xining, China; Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province (Qinghai-Utah Loint Research Key Lab for High Altitude Medicine), Xining, China. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Apr 01; Vol. 270, pp. 119012. Date of Electronic Publication: 2021 Jan 08.
Typ publikacji :
Journal Article
MeSH Terms :
Altitude Sickness/*metabolism
Cognitive Dysfunction/*drug therapy
Memantine/*pharmacology
Altitude ; Altitude Sickness/drug therapy ; Alzheimer Disease/drug therapy ; Animals ; Cell Death/drug effects ; Cognition/drug effects ; Disease Models, Animal ; Excitatory Amino Acid Antagonists/pharmacology ; Glutamic Acid/metabolism ; Hippocampus/metabolism ; Hypoxia/metabolism ; Male ; Memantine/metabolism ; Memory/drug effects ; Neurons/drug effects ; Neuroprotective Agents/pharmacology ; Neurotoxins/metabolism ; Oxidative Stress/drug effects ; Rats ; Rats, Sprague-Dawley ; Receptors, N-Methyl-D-Aspartate/metabolism
Czasopismo naukowe
Tytuł :
[Anti-inflammatory effects of amantadine and memantine in SARS-CoV-2 infection].
Autorzy :
Plusa T; Medical Faculty of Lazarski University in Warsaw.
Pokaż więcej
Transliterated Title :
Przeciwzapalne działanie amantadyny i memantyny w zakażeniu SARS-CoV-2.
Źródło :
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego [Pol Merkur Lekarski] 2021 Feb 24; Vol. 49 (289), pp. 67-70.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*
Memantine*/pharmacology
Memantine*/therapeutic use
Amantadine/pharmacology ; Amantadine/therapeutic use ; Anti-Inflammatory Agents ; Humans ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Effect of Memantine on Pentylenetetrazol-induced Seizures and EEG Profile in Animal Model of Cortical Malformation.
Autorzy :
Lazzarotto G; Neurophysiology and Neurochemistry of Neuronal Excitability and Synaptic Plasticity Laboratory (NNNESP Lab.), Department of Biochemistry, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Graduate Program in Neuroscience, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Klippel Zanona Q; Neurophysiology and Neurochemistry of Neuronal Excitability and Synaptic Plasticity Laboratory (NNNESP Lab.), Department of Biochemistry, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Graduate Program in Neuroscience, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Cagliari Zenki K; Graduate Program in Biological Sciences: Biochemistry, Department of Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Calcagnotto ME; Neurophysiology and Neurochemistry of Neuronal Excitability and Synaptic Plasticity Laboratory (NNNESP Lab.), Department of Biochemistry, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Graduate Program in Neuroscience, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Graduate Program in Biological Sciences: Biochemistry, Department of Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Electronic address: .
Pokaż więcej
Źródło :
Neuroscience [Neuroscience] 2021 Mar 01; Vol. 457, pp. 114-124. Date of Electronic Publication: 2021 Jan 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Memantine*/pharmacology
Pentylenetetrazole*/toxicity
Animals ; Disease Models, Animal ; Electroencephalography ; Male ; Rats ; Rats, Wistar ; Seizures/chemically induced ; Seizures/drug therapy
Czasopismo naukowe
Tytuł :
Add-on memantine may improve cognitive functions and attenuate inflammation in middle- to old-aged bipolar II disorder patients.
Autorzy :
Lu RB; Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Yanjiao Furen Hospital, Hebei, China.
Wang TY; Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Electronic address: .
Lee SY; Department of Psychiatry, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Chang YH; Department of Psychology, Asia University, Taichung, Taiwan; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Chen SL; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Lipid Science and Aging Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
Tsai TY; Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Chen PS; Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Huang SY; Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Tzeng NS; Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; Student Counseling Center, National Defense Medical Center, Taipei, Taiwan.
Lee IH; Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Chen KC; Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Yang YK; Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Psychiatry, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan.
Hong JS; Neurobiology Laboratory, NIH/NIEHS, Research Triangle Park, NC, USA.
Pokaż więcej
Źródło :
Journal of affective disorders [J Affect Disord] 2021 Jan 15; Vol. 279, pp. 229-238. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Bipolar Disorder*/drug therapy
Memantine*/therapeutic use
Aged ; Cognition ; Double-Blind Method ; Drug Therapy, Combination ; Humans ; Inflammation/drug therapy ; Middle Aged ; Valproic Acid/therapeutic use
Czasopismo naukowe
Tytuł :
Multiple target-based combination therapy of galantamine, memantine and lycopene for the possible treatment of Alzheimer's disease.
Autorzy :
Vishwas S; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India.
Awasthi A; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India.
Corrie L; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India.
Kumar Singh S; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India. Electronic address: .
Gulati M; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India.
Pokaż więcej
Źródło :
Medical hypotheses [Med Hypotheses] 2020 Oct; Vol. 143, pp. 109879. Date of Electronic Publication: 2020 May 25.
Typ publikacji :
Journal Article
MeSH Terms :
Alzheimer Disease*/drug therapy
Memantine*/therapeutic use
Cholinesterase Inhibitors/therapeutic use ; Donepezil ; Galantamine/therapeutic use ; Humans ; Indans ; Lycopene ; Piperidines
Czasopismo naukowe
Tytuł :
Hippocampal Avoidance Whole-Brain Radiotherapy (WBRT) Versus WBRT in Patients With Brain Metastases: Were Hippocampi the Only Difference?
Autorzy :
Levy A; Antonin Levy, MD, PhD, Department of Radiation Oncology and INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, Villejuif, France, and Université Paris Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France; and Frédéric Dhermain, MD, PhD; Angela Botticella, MD; Sofia Rivera, MD, PhD; and Cécile Le Péchoux, MD, Department of Radiation Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Dhermain F; Antonin Levy, MD, PhD, Department of Radiation Oncology and INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, Villejuif, France, and Université Paris Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France; and Frédéric Dhermain, MD, PhD; Angela Botticella, MD; Sofia Rivera, MD, PhD; and Cécile Le Péchoux, MD, Department of Radiation Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Botticella A; Antonin Levy, MD, PhD, Department of Radiation Oncology and INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, Villejuif, France, and Université Paris Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France; and Frédéric Dhermain, MD, PhD; Angela Botticella, MD; Sofia Rivera, MD, PhD; and Cécile Le Péchoux, MD, Department of Radiation Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Rivera S; Antonin Levy, MD, PhD, Department of Radiation Oncology and INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, Villejuif, France, and Université Paris Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France; and Frédéric Dhermain, MD, PhD; Angela Botticella, MD; Sofia Rivera, MD, PhD; and Cécile Le Péchoux, MD, Department of Radiation Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Le Péchoux C; Antonin Levy, MD, PhD, Department of Radiation Oncology and INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, Villejuif, France, and Université Paris Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France; and Frédéric Dhermain, MD, PhD; Angela Botticella, MD; Sofia Rivera, MD, PhD; and Cécile Le Péchoux, MD, Department of Radiation Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Oct 10; Vol. 38 (29), pp. 3453-3454. Date of Electronic Publication: 2020 Aug 12.
Typ publikacji :
Letter; Comment
MeSH Terms :
Brain Neoplasms*/radiotherapy
Memantine*
Cranial Irradiation/adverse effects ; Hippocampus ; Humans
Opinia redakcyjna
Tytuł :
Reply to S.G. Chun et al, A. Levy et al, and N. Andratschke et al.
Autorzy :
Gondi V; Vinai Gondi, MD, Northwestern Medicine Cancer Center Warrenville and Northwestern Medicine Proton Center, Warrenville, IL; and Paul D. Brown, MD, Mayo Clinic, Rochester, MN.
Brown PD; Vinai Gondi, MD, Northwestern Medicine Cancer Center Warrenville and Northwestern Medicine Proton Center, Warrenville, IL; and Paul D. Brown, MD, Mayo Clinic, Rochester, MN.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Oct 10; Vol. 38 (29), pp. 3455-3457. Date of Electronic Publication: 2020 Aug 12.
Typ publikacji :
Letter; Research Support, N.I.H., Extramural; Comment
MeSH Terms :
Brain Neoplasms*
Memantine*
Hippocampus ; Humans ; Medical Oncology
Raport
Tytuł :
Hippocampal Avoidance and Memantine for Whole-Brain Radiotherapy: Long-Term Follow-Up Warranted.
Autorzy :
Andratschke N; Nicolaus Andratschke, MD, Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland; José Belderbos, MD, PhD, Department of Radiation Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Michael Mayinger, MD, Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland; Sanne B. Schagen, PhD, Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute, Amsterdam, The Netherlands; and Dirk De Ruysscher, MD, PhD, Department of Radiotherapy (Maastro), Maastricht University Medical Center, GROW Research Institute, Maastricht, the Netherlands.
Belderbos J; Nicolaus Andratschke, MD, Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland; José Belderbos, MD, PhD, Department of Radiation Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Michael Mayinger, MD, Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland; Sanne B. Schagen, PhD, Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute, Amsterdam, The Netherlands; and Dirk De Ruysscher, MD, PhD, Department of Radiotherapy (Maastro), Maastricht University Medical Center, GROW Research Institute, Maastricht, the Netherlands.
Mayinger M; Nicolaus Andratschke, MD, Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland; José Belderbos, MD, PhD, Department of Radiation Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Michael Mayinger, MD, Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland; Sanne B. Schagen, PhD, Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute, Amsterdam, The Netherlands; and Dirk De Ruysscher, MD, PhD, Department of Radiotherapy (Maastro), Maastricht University Medical Center, GROW Research Institute, Maastricht, the Netherlands.
Schagen SB; Nicolaus Andratschke, MD, Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland; José Belderbos, MD, PhD, Department of Radiation Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Michael Mayinger, MD, Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland; Sanne B. Schagen, PhD, Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute, Amsterdam, The Netherlands; and Dirk De Ruysscher, MD, PhD, Department of Radiotherapy (Maastro), Maastricht University Medical Center, GROW Research Institute, Maastricht, the Netherlands.
De Ruysscher D; Nicolaus Andratschke, MD, Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland; José Belderbos, MD, PhD, Department of Radiation Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Michael Mayinger, MD, Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland; Sanne B. Schagen, PhD, Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute, Amsterdam, The Netherlands; and Dirk De Ruysscher, MD, PhD, Department of Radiotherapy (Maastro), Maastricht University Medical Center, GROW Research Institute, Maastricht, the Netherlands.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Oct 10; Vol. 38 (29), pp. 3454-3455. Date of Electronic Publication: 2020 Aug 12.
Typ publikacji :
Letter; Comment
MeSH Terms :
Brain Neoplasms*/drug therapy
Brain Neoplasms*/radiotherapy
Memantine*/therapeutic use
Cranial Irradiation/adverse effects ; Follow-Up Studies ; Hippocampus ; Humans
Opinia redakcyjna
Tytuł :
Delayed Adjunctive Treatment of Organophosphate-Induced Status Epilepticus in Rats with Phenobarbital, Memantine, or Dexmedetomidine.
Autorzy :
Spampanato J; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah .
Bealer SL; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah.
Smolik M; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah.
Dudek FE; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah.
Pokaż więcej
Źródło :
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2020 Oct; Vol. 375 (1), pp. 59-68. Date of Electronic Publication: 2020 Sep 01.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Time-to-Treatment*
Anticonvulsants/*administration & dosage
Dexmedetomidine/*administration & dosage
Isoflurophate/*poisoning
Memantine/*administration & dosage
Phenobarbital/*administration & dosage
Status Epilepticus/*drug therapy
Animals ; Anticonvulsants/therapeutic use ; Brain/drug effects ; Brain/pathology ; Cell Death/drug effects ; Dexmedetomidine/therapeutic use ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Drug Interactions ; Electroencephalography ; Male ; Memantine/therapeutic use ; Neurons/drug effects ; Neurons/pathology ; Phenobarbital/therapeutic use ; Rats ; Rats, Sprague-Dawley ; Status Epilepticus/chemically induced ; Status Epilepticus/pathology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Memantine Derivatives as Multitarget Agents in Alzheimer's Disease.
Autorzy :
Marotta G; Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.
Basagni F; Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.
Rosini M; Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.
Minarini A; Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2020 Sep 02; Vol. 25 (17). Date of Electronic Publication: 2020 Sep 02.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Alzheimer Disease/*drug therapy
Memantine/*therapeutic use
Animals ; Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Cholinesterase Inhibitors/chemistry ; Cholinesterase Inhibitors/pharmacology ; Drug Design ; Humans ; Memantine/chemistry ; Memantine/pharmacology ; Models, Molecular
Czasopismo naukowe
Tytuł :
Is Memantine Effective as an NMDA-Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
Autorzy :
Kikuchi T; New Drug Research Division, Pharmaceutical Business Division, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-0192, Japan.
Pokaż więcej
Źródło :
Biomolecules [Biomolecules] 2020 Jul 31; Vol. 10 (8). Date of Electronic Publication: 2020 Jul 31.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antipsychotic Agents/*therapeutic use
Excitatory Amino Acid Antagonists/*therapeutic use
Memantine/*therapeutic use
Receptors, N-Methyl-D-Aspartate/*antagonists & inhibitors
Schizophrenia/*drug therapy
Animals ; Antipsychotic Agents/administration & dosage ; Antipsychotic Agents/adverse effects ; Drug Combinations ; Excitatory Amino Acid Antagonists/administration & dosage ; Excitatory Amino Acid Antagonists/adverse effects ; Humans ; Memantine/administration & dosage ; Memantine/adverse effects
Czasopismo naukowe
Tytuł :
Cardioprotective effects of memantine in myocardial ischemia: Ex vivo and in vivo studies.
Autorzy :
Jannesar K; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran. Electronic address: .
Abbaszadeh S; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran. Electronic address: .
Malekinejad H; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran. Electronic address: .
Soraya H; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran. Electronic address: .
Pokaż więcej
Źródło :
European journal of pharmacology [Eur J Pharmacol] 2020 Sep 05; Vol. 882, pp. 173277. Date of Electronic Publication: 2020 Jun 13.
Typ publikacji :
Journal Article
MeSH Terms :
Cardiomegaly/*drug therapy
Cardiotonic Agents/*therapeutic use
Memantine/*therapeutic use
Myocardial Infarction/*drug therapy
Animals ; Cardiomegaly/chemically induced ; Cardiomegaly/metabolism ; Cardiomegaly/pathology ; Cardiotonic Agents/pharmacology ; Isoproterenol ; Lipid Peroxidation/drug effects ; Male ; Malondialdehyde/metabolism ; Memantine/pharmacology ; Myocardial Infarction/chemically induced ; Myocardial Infarction/pathology ; Myocardium/metabolism ; Myocardium/pathology ; Oxidative Stress/drug effects ; Rats, Wistar ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł :
Memantine Improves Depressive-like Behaviors via Kir6.1 Channel Inhibition in Olfactory Bulbectomized Mice.
Autorzy :
Moriguchi S; Research Center for Pharmaceutical Development, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan; Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. Electronic address: .
Inagaki R; Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Shimojo H; Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Sugimura Y; Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Fukunaga K; Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Pokaż więcej
Źródło :
Neuroscience [Neuroscience] 2020 Aug 21; Vol. 442, pp. 264-273. Date of Electronic Publication: 2020 Jun 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Memantine*/pharmacology
Olfactory Bulb*
Animals ; Depression/drug therapy ; Hippocampus ; KATP Channels ; Mice
Czasopismo naukowe
Tytuł :
A rapid FTIR spectroscopic assay for quantitative determination of Memantine hydrochloride and Amisulpride in human plasma and pharmaceutical formulations.
Autorzy :
Atia NN; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.
Marzouq MA; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt.
Hassan AI; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt.
Eltoukhi WE; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt. Electronic address: .
Pokaż więcej
Źródło :
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2020 Aug 05; Vol. 236, pp. 118377. Date of Electronic Publication: 2020 Apr 15.
Typ publikacji :
Journal Article
MeSH Terms :
Amisulpride/*analysis
Memantine/*analysis
Spectroscopy, Fourier Transform Infrared/*methods
Amisulpride/blood ; Excipients ; Humans ; Limit of Detection ; Memantine/blood ; Reproducibility of Results ; Tablets/analysis ; Time Factors
Czasopismo naukowe
Tytuł :
Safety and efficacy of memantine for multiple sclerosis-related fatigue: A pilot randomized, double-blind placebo-controlled trial.
Autorzy :
Falsafi Z; Department of Neurology, Alavi Hospital, Ardabil University of Medical Sciences, Ardabil, Iran.
Tafakhori A; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Agah E; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran; NeuroImmunology Research Association (NIRA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Mojarrad M; School of medicine, Tehran University of Medical Sciences, Tehran, Iran.
Dehghani R; Molecular Immunology Research Center, School of Medicine, Tehran University of Medical Science, Tehran 1419783151, Iran; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Los Angeles, CA 90001, USA.
Ghaffarpour M; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: .
Aghamollaii V; Department of Neurology, Roozbeh Hospital, Tehran University of Medical Sciences, Roozbeh Hospital, Tehran, Iran.
Mousavi SV; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran; NeuroImmunology Research Association (NIRA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Fouladi Z; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Pourghaz B; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Balali P; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Harirchian MH; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: .
Pokaż więcej
Źródło :
Journal of the neurological sciences [J Neurol Sci] 2020 Jul 15; Vol. 414, pp. 116844. Date of Electronic Publication: 2020 Apr 17.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Memantine*/therapeutic use
Multiple Sclerosis*/complications
Multiple Sclerosis*/drug therapy
Double-Blind Method ; Fatigue/drug therapy ; Fatigue/etiology ; Humans ; Pilot Projects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Nanoporous microneedle arrays seamlessly connected to a drug reservoir for tunable transdermal delivery of memantine.
Autorzy :
Vos PJ; MyLife Technologies B.V., Leiden Bio Science Park, BioPartner 4, Robert Boyleweg 4, Unit 4358, 2333 CG Leiden, the Netherlands. Electronic address: .
Kuijt N; MyLife Technologies B.V., Leiden Bio Science Park, BioPartner 4, Robert Boyleweg 4, Unit 4358, 2333 CG Leiden, the Netherlands.
Kaya M; MyLife Technologies B.V., Leiden Bio Science Park, BioPartner 4, Robert Boyleweg 4, Unit 4358, 2333 CG Leiden, the Netherlands.
Rol S; MyLife Technologies B.V., Leiden Bio Science Park, BioPartner 4, Robert Boyleweg 4, Unit 4358, 2333 CG Leiden, the Netherlands.
van der Maaden K; MyLife Technologies B.V., Leiden Bio Science Park, BioPartner 4, Robert Boyleweg 4, Unit 4358, 2333 CG Leiden, the Netherlands; Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Einsteinweg 55, 2333 CC Leiden, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2020 Jul 01; Vol. 150, pp. 105331. Date of Electronic Publication: 2020 May 26.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Delivery Systems*
Microinjections*
Needles*
Memantine/*administration & dosage
Neuroprotective Agents/*administration & dosage
Administration, Cutaneous ; Animals ; Memantine/blood ; Memantine/pharmacokinetics ; Nanopores ; Neuroprotective Agents/blood ; Neuroprotective Agents/pharmacokinetics ; Porosity ; Swine ; Swine, Miniature
Czasopismo naukowe
Tytuł :
The CITIMEM study: A pilot study. Optimizing pharmacological treatment in dementia.
Autorzy :
Gareri P; Center for Cognitive Disorders and Dementia - Catanzaro Lido, ASP Catanzaro, Catanzaro, Italy. Electronic address: .
Cotroneo AM; Department of Elderly Health Care - Birago di Vische Hospital and Botticelli Territorial Geriatrics - ASL TO 2, Turin, Italy. Electronic address: .
Orsitto G; U.O.C. Internal Medicine Ward, P.O. Bari Sud 'Di Venere', Bari, Azienda Sanitaria Locale di Bari, Italy. Electronic address: .
Putignano S; Operative Unit Elderly Care, District 30, ASL Napoli Centro, Italy. Electronic address: .
Pokaż więcej
Źródło :
Archives of gerontology and geriatrics [Arch Gerontol Geriatr] 2020 Jul - Aug; Vol. 89, pp. 104073. Date of Electronic Publication: 2020 May 16.
Typ publikacji :
Journal Article
MeSH Terms :
Activities of Daily Living*
Alzheimer Disease*/drug therapy
Antiparkinson Agents*/therapeutic use
Memantine*/therapeutic use
Aged ; Aged, 80 and over ; Humans ; Pilot Projects ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Memantine effects on ingestion microstructure and the effect of administration time: A within-subject study.
Autorzy :
Galistu A; Dipartimento di Scienze Biomediche, Università di Sassari, Sassari, Italy.
D'Aquila PS; Dipartimento di Scienze Biomediche, Università di Sassari, Sassari, Italy.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Sep 16; Vol. 15 (9), pp. e0239270. Date of Electronic Publication: 2020 Sep 16 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Feeding Behavior/*drug effects
Memantine/*pharmacology
Memory/*drug effects
Receptors, N-Methyl-D-Aspartate/*antagonists & inhibitors
Animals ; Conditioning, Classical/drug effects ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Drinking Behavior/drug effects ; Eating ; Humans ; Memantine/adverse effects ; Memory/physiology ; Rats ; Receptors, N-Methyl-D-Aspartate/genetics
Czasopismo naukowe
Tytuł :
Combined treatment with escitalopram and memantine increases gray matter volume and cortical thickness compared to escitalopram and placebo in a pilot study of geriatric depression.
Autorzy :
Krause-Sorio B; Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095, USA. Electronic address: .
Siddarth P; Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095, USA. Electronic address: .
Kilpatrick L; Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095, USA. Electronic address: .
Laird KT; Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095, USA.
Milillo MM; Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095, USA.
Ercoli L; Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095, USA. Electronic address: .
Narr KL; Department of Neurology, 635 Charles E. Young Drive South, Los Angeles, CA 90095, USA. Electronic address: .
Lavretsky H; Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095, USA. Electronic address: .
Pokaż więcej
Źródło :
Journal of affective disorders [J Affect Disord] 2020 Sep 01; Vol. 274, pp. 464-470. Date of Electronic Publication: 2020 May 24.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Citalopram*/therapeutic use
Memantine*/therapeutic use
Adult ; Aged ; Depression ; Double-Blind Method ; Female ; Gray Matter/diagnostic imaging ; Humans ; Pilot Projects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies